Cystatin B inhibition of TRAIL-induced apoptosis is associated with the protection of FLIPL from degradation by the E3 ligase itch ... View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2010-03-19

AUTHORS

F Yang, K H Tay, L Dong, R F Thorne, C C Jiang, E Yang, H-Y Tseng, H Liu, R Christopherson, P Hersey, X D Zhang

ABSTRACT

Past studies have identified a number of distinct mechanisms that contribute to the resistance of melanoma cells against apoptosis induced by TNF-related apoptosis-inducing ligand (TRAIL). In this report we show that cystatin B is another endogenous inhibitor of TRAIL-induced apoptosis. Cystatin B-deficient melanoma cell lines established by shRNA knockdown displayed increased apoptosis that was associated with enhanced activation of caspase-8 induced by TRAIL. This was not related to the inhibitory effect of cystatin B on the lysosomal cysteine proteases, cathepsin B and L, as they did not have a role in TRAIL-induced apoptosis in most melanoma cell lines even when cystatin B was inhibited. Instead, sensitization of melanoma cells to TRAIL-induced apoptosis by inhibition of cystatin B appeared associated with decreased stability of FLIPL as the levels of FLIPL were reduced because of shortened half-life time in melanoma cells deficient in cystatin B. In contrast, over-expression of cystatin B increased the levels of FLIPL, decreased the amount of the E3 ligase Itch associated with FLIPL, and reduced FLIPL ubiquitination. Inhibition of Itch by siRNA restored the levels of FLIPL and blocked sensitization to TRAIL-induced apoptosis associated with deficiency in cystatin B. Taken together, these results indicate that cystatin B regulates Itch-mediated degradation of FLIPL and thereby TRAIL-induced apoptosis in melanoma cells. More... »

PAGES

1354-1367

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/cdd.2010.29

DOI

http://dx.doi.org/10.1038/cdd.2010.29

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1035034614

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/20300110


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Apoptosis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "CASP8 and FADD-Like Apoptosis Regulating Protein", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Caspase 8", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Line, Tumor", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cystatin B", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Gene Knockdown Techniques", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Melanoma", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "RNA Interference", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "RNA, Small Interfering", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Repressor Proteins", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "TNF-Related Apoptosis-Inducing Ligand", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Ubiquitin-Protein Ligases", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Immunology and Oncology Unit, Calvary Mater Newcastle Hospital, 2300, Newcastle, NSW, Australia", 
          "id": "http://www.grid.ac/institutes/grid.413265.7", 
          "name": [
            "Immunology and Oncology Unit, Calvary Mater Newcastle Hospital, 2300, Newcastle, NSW, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yang", 
        "givenName": "F", 
        "id": "sg:person.0755651204.44", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0755651204.44"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Immunology and Oncology Unit, Calvary Mater Newcastle Hospital, 2300, Newcastle, NSW, Australia", 
          "id": "http://www.grid.ac/institutes/grid.413265.7", 
          "name": [
            "Immunology and Oncology Unit, Calvary Mater Newcastle Hospital, 2300, Newcastle, NSW, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tay", 
        "givenName": "K H", 
        "id": "sg:person.01204255216.26", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01204255216.26"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Immunology and Oncology Unit, Calvary Mater Newcastle Hospital, 2300, Newcastle, NSW, Australia", 
          "id": "http://www.grid.ac/institutes/grid.413265.7", 
          "name": [
            "Immunology and Oncology Unit, Calvary Mater Newcastle Hospital, 2300, Newcastle, NSW, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Dong", 
        "givenName": "L", 
        "id": "sg:person.01136142016.09", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01136142016.09"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Immunology and Oncology Unit, Calvary Mater Newcastle Hospital, 2300, Newcastle, NSW, Australia", 
          "id": "http://www.grid.ac/institutes/grid.413265.7", 
          "name": [
            "Immunology and Oncology Unit, Calvary Mater Newcastle Hospital, 2300, Newcastle, NSW, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Thorne", 
        "givenName": "R F", 
        "id": "sg:person.01210202271.19", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01210202271.19"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Immunology and Oncology Unit, Calvary Mater Newcastle Hospital, 2300, Newcastle, NSW, Australia", 
          "id": "http://www.grid.ac/institutes/grid.413265.7", 
          "name": [
            "Immunology and Oncology Unit, Calvary Mater Newcastle Hospital, 2300, Newcastle, NSW, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Jiang", 
        "givenName": "C C", 
        "id": "sg:person.0617201523.26", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0617201523.26"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "School of Molecular and Microbial Biosciences, University of Sydney, 2006, Sydney, NSW, Australia", 
          "id": "http://www.grid.ac/institutes/grid.1013.3", 
          "name": [
            "School of Molecular and Microbial Biosciences, University of Sydney, 2006, Sydney, NSW, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yang", 
        "givenName": "E", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Immunology and Oncology Unit, Calvary Mater Newcastle Hospital, 2300, Newcastle, NSW, Australia", 
          "id": "http://www.grid.ac/institutes/grid.413265.7", 
          "name": [
            "Immunology and Oncology Unit, Calvary Mater Newcastle Hospital, 2300, Newcastle, NSW, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tseng", 
        "givenName": "H-Y", 
        "id": "sg:person.01032164214.33", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01032164214.33"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Immunology and Oncology Unit, Calvary Mater Newcastle Hospital, 2300, Newcastle, NSW, Australia", 
          "id": "http://www.grid.ac/institutes/grid.413265.7", 
          "name": [
            "Immunology and Oncology Unit, Calvary Mater Newcastle Hospital, 2300, Newcastle, NSW, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Liu", 
        "givenName": "H", 
        "id": "sg:person.01212142420.00", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01212142420.00"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "School of Molecular and Microbial Biosciences, University of Sydney, 2006, Sydney, NSW, Australia", 
          "id": "http://www.grid.ac/institutes/grid.1013.3", 
          "name": [
            "School of Molecular and Microbial Biosciences, University of Sydney, 2006, Sydney, NSW, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Christopherson", 
        "givenName": "R", 
        "id": "sg:person.01173405121.07", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01173405121.07"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Immunology and Oncology Unit, Calvary Mater Newcastle Hospital, 2300, Newcastle, NSW, Australia", 
          "id": "http://www.grid.ac/institutes/grid.413265.7", 
          "name": [
            "Immunology and Oncology Unit, Calvary Mater Newcastle Hospital, 2300, Newcastle, NSW, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hersey", 
        "givenName": "P", 
        "id": "sg:person.01073667716.42", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01073667716.42"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Immunology and Oncology Unit, Calvary Mater Newcastle Hospital, 2300, Newcastle, NSW, Australia", 
          "id": "http://www.grid.ac/institutes/grid.413265.7", 
          "name": [
            "Immunology and Oncology Unit, Calvary Mater Newcastle Hospital, 2300, Newcastle, NSW, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zhang", 
        "givenName": "X D", 
        "id": "sg:person.01210116316.18", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01210116316.18"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/sj.onc.1210924", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049640882", 
          "https://doi.org/10.1038/sj.onc.1210924"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.onc.1207512", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019973027", 
          "https://doi.org/10.1038/sj.onc.1207512"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.onc.1204673", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000652031", 
          "https://doi.org/10.1038/sj.onc.1204673"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.onc.1210624", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022683071", 
          "https://doi.org/10.1038/sj.onc.1210624"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/40657", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027258655", 
          "https://doi.org/10.1038/40657"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/cdd.2009.35", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000450113", 
          "https://doi.org/10.1038/cdd.2009.35"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/onc.2008.299", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005671810", 
          "https://doi.org/10.1038/onc.2008.299"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.cdd.4400859", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027216678", 
          "https://doi.org/10.1038/sj.cdd.4400859"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/35101078", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021222128", 
          "https://doi.org/10.1038/35101078"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.cdd.4401416", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038685270", 
          "https://doi.org/10.1038/sj.cdd.4401416"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00432-005-0053-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031193330", 
          "https://doi.org/10.1007/s00432-005-0053-9"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2010-03-19", 
    "datePublishedReg": "2010-03-19", 
    "description": "Past studies have identified a number of distinct mechanisms that contribute to the resistance of melanoma cells against apoptosis induced by TNF-related apoptosis-inducing ligand (TRAIL). In this report we show that cystatin B is another endogenous inhibitor of TRAIL-induced apoptosis. Cystatin B-deficient melanoma cell lines established by shRNA knockdown displayed increased apoptosis that was associated with enhanced activation of caspase-8 induced by TRAIL. This was not related to the inhibitory effect of cystatin B on the lysosomal cysteine proteases, cathepsin B and L, as they did not have a role in TRAIL-induced apoptosis in most melanoma cell lines even when cystatin B was inhibited. Instead, sensitization of melanoma cells to TRAIL-induced apoptosis by inhibition of cystatin B appeared associated with decreased stability of FLIPL as the levels of FLIPL were reduced because of shortened half-life time in melanoma cells deficient in cystatin B. In contrast, over-expression of cystatin B increased the levels of FLIPL, decreased the amount of the E3 ligase Itch associated with FLIPL, and reduced FLIPL ubiquitination. Inhibition of Itch by siRNA restored the levels of FLIPL and blocked sensitization to TRAIL-induced apoptosis associated with deficiency in cystatin B. Taken together, these results indicate that cystatin B regulates Itch-mediated degradation of FLIPL and thereby TRAIL-induced apoptosis in melanoma cells.", 
    "genre": "article", 
    "id": "sg:pub.10.1038/cdd.2010.29", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1112551", 
        "issn": [
          "1350-9047", 
          "1476-5403"
        ], 
        "name": "Cell Death & Differentiation", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "8", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "17"
      }
    ], 
    "keywords": [
      "TRAIL-induced apoptosis", 
      "melanoma cells", 
      "melanoma cell lines", 
      "cystatin B", 
      "inhibition of itch", 
      "most melanoma cell lines", 
      "cell lines", 
      "cystatin B.", 
      "human melanoma cells", 
      "apoptosis-inducing ligand", 
      "lysosomal cysteine protease", 
      "E3 ligase Itch", 
      "inhibitory effect", 
      "itch", 
      "endogenous inhibitor", 
      "enhanced activation", 
      "shRNA knockdown", 
      "B inhibition", 
      "apoptosis", 
      "cathepsin B", 
      "inhibition", 
      "sensitization", 
      "caspase-8", 
      "cells", 
      "FLIPL", 
      "distinct mechanisms", 
      "cysteine proteases", 
      "B.", 
      "TNF", 
      "levels", 
      "siRNA", 
      "inhibitors", 
      "knockdown", 
      "half-life time", 
      "activation", 
      "deficiency", 
      "report", 
      "trails", 
      "expression", 
      "decreased stability", 
      "protease", 
      "study", 
      "lines", 
      "role", 
      "ubiquitination", 
      "contrast", 
      "effect", 
      "resistance", 
      "protection", 
      "past studies", 
      "mechanism", 
      "number", 
      "time", 
      "ligands", 
      "results", 
      "amount", 
      "degradation", 
      "stability"
    ], 
    "name": "Cystatin B inhibition of TRAIL-induced apoptosis is associated with the protection of FLIPL from degradation by the E3 ligase itch in human melanoma cells", 
    "pagination": "1354-1367", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1035034614"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/cdd.2010.29"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "20300110"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/cdd.2010.29", 
      "https://app.dimensions.ai/details/publication/pub.1035034614"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-09-02T15:55", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220902/entities/gbq_results/article/article_515.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1038/cdd.2010.29"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/cdd.2010.29'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/cdd.2010.29'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/cdd.2010.29'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/cdd.2010.29'


 

This table displays all metadata directly associated to this object as RDF triples.

287 TRIPLES      21 PREDICATES      107 URIs      88 LITERALS      20 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/cdd.2010.29 schema:about N092eadbe6f87433d92a8a851b3dc9816
2 N1c640d4a955e486494ddb5027a867730
3 N6370a04957344920998f7ff035bf1b71
4 N666c4f20898e4f55a846809e40363eff
5 N7761f8bb2fd54287962318f895703e57
6 N89fe92b78413416faab7b0e6b6d4d1dd
7 Na95a147c828f4b0ebf3c56e469ccc76b
8 Nafe4cc1fbf6749b5a4386be89350173f
9 Nbf32d93d211e46e1aacde2aa99f0ce37
10 Nd36c2511085f44f2a8e1f4b74cce5e35
11 Ndd236ea2d327405aa2003274c2f1a1d2
12 Nebe8606b27e944a8951af343585f2b6a
13 Nf530e5741d9442f0a82d7bbf3d7532e2
14 anzsrc-for:11
15 anzsrc-for:1112
16 schema:author Nc0bbecef9dd24feb9ab77c0391d445fd
17 schema:citation sg:pub.10.1007/s00432-005-0053-9
18 sg:pub.10.1038/35101078
19 sg:pub.10.1038/40657
20 sg:pub.10.1038/cdd.2009.35
21 sg:pub.10.1038/onc.2008.299
22 sg:pub.10.1038/sj.cdd.4400859
23 sg:pub.10.1038/sj.cdd.4401416
24 sg:pub.10.1038/sj.onc.1204673
25 sg:pub.10.1038/sj.onc.1207512
26 sg:pub.10.1038/sj.onc.1210624
27 sg:pub.10.1038/sj.onc.1210924
28 schema:datePublished 2010-03-19
29 schema:datePublishedReg 2010-03-19
30 schema:description Past studies have identified a number of distinct mechanisms that contribute to the resistance of melanoma cells against apoptosis induced by TNF-related apoptosis-inducing ligand (TRAIL). In this report we show that cystatin B is another endogenous inhibitor of TRAIL-induced apoptosis. Cystatin B-deficient melanoma cell lines established by shRNA knockdown displayed increased apoptosis that was associated with enhanced activation of caspase-8 induced by TRAIL. This was not related to the inhibitory effect of cystatin B on the lysosomal cysteine proteases, cathepsin B and L, as they did not have a role in TRAIL-induced apoptosis in most melanoma cell lines even when cystatin B was inhibited. Instead, sensitization of melanoma cells to TRAIL-induced apoptosis by inhibition of cystatin B appeared associated with decreased stability of FLIPL as the levels of FLIPL were reduced because of shortened half-life time in melanoma cells deficient in cystatin B. In contrast, over-expression of cystatin B increased the levels of FLIPL, decreased the amount of the E3 ligase Itch associated with FLIPL, and reduced FLIPL ubiquitination. Inhibition of Itch by siRNA restored the levels of FLIPL and blocked sensitization to TRAIL-induced apoptosis associated with deficiency in cystatin B. Taken together, these results indicate that cystatin B regulates Itch-mediated degradation of FLIPL and thereby TRAIL-induced apoptosis in melanoma cells.
31 schema:genre article
32 schema:isAccessibleForFree true
33 schema:isPartOf N59c0c93bcf2d4f4ba0798b294a27444a
34 Nd391a4072161472c9563f53a91c0b28b
35 sg:journal.1112551
36 schema:keywords B inhibition
37 B.
38 E3 ligase Itch
39 FLIPL
40 TNF
41 TRAIL-induced apoptosis
42 activation
43 amount
44 apoptosis
45 apoptosis-inducing ligand
46 caspase-8
47 cathepsin B
48 cell lines
49 cells
50 contrast
51 cystatin B
52 cystatin B.
53 cysteine proteases
54 decreased stability
55 deficiency
56 degradation
57 distinct mechanisms
58 effect
59 endogenous inhibitor
60 enhanced activation
61 expression
62 half-life time
63 human melanoma cells
64 inhibition
65 inhibition of itch
66 inhibitors
67 inhibitory effect
68 itch
69 knockdown
70 levels
71 ligands
72 lines
73 lysosomal cysteine protease
74 mechanism
75 melanoma cell lines
76 melanoma cells
77 most melanoma cell lines
78 number
79 past studies
80 protease
81 protection
82 report
83 resistance
84 results
85 role
86 sensitization
87 shRNA knockdown
88 siRNA
89 stability
90 study
91 time
92 trails
93 ubiquitination
94 schema:name Cystatin B inhibition of TRAIL-induced apoptosis is associated with the protection of FLIPL from degradation by the E3 ligase itch in human melanoma cells
95 schema:pagination 1354-1367
96 schema:productId N2693c87a00404b279f742acd360e343c
97 N95b897cc2a864a36801b644d483f5f43
98 Na2b1220108794ed1a7072f22813996a3
99 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035034614
100 https://doi.org/10.1038/cdd.2010.29
101 schema:sdDatePublished 2022-09-02T15:55
102 schema:sdLicense https://scigraph.springernature.com/explorer/license/
103 schema:sdPublisher Nc90084c4105746d598029b4f7ae3e881
104 schema:url https://doi.org/10.1038/cdd.2010.29
105 sgo:license sg:explorer/license/
106 sgo:sdDataset articles
107 rdf:type schema:ScholarlyArticle
108 N092eadbe6f87433d92a8a851b3dc9816 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
109 schema:name TNF-Related Apoptosis-Inducing Ligand
110 rdf:type schema:DefinedTerm
111 N1c640d4a955e486494ddb5027a867730 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
112 schema:name Cell Line, Tumor
113 rdf:type schema:DefinedTerm
114 N2693c87a00404b279f742acd360e343c schema:name pubmed_id
115 schema:value 20300110
116 rdf:type schema:PropertyValue
117 N2a1aa56929d4403b92ea99ba9e35f5dd rdf:first sg:person.01210116316.18
118 rdf:rest rdf:nil
119 N2bd267cd1da94cd5880bfe1b83732ed0 rdf:first Nb608f8e88aaf48868462ac8386db475b
120 rdf:rest N7b177bb7489c49efb0b14d1fc3c711aa
121 N43d6eef20c2548f495e497249fadc3f4 rdf:first sg:person.01204255216.26
122 rdf:rest N752e12e3162f4f57a3daa29ccc04d176
123 N578f701717b3428cae2d409a5c44fe32 rdf:first sg:person.01212142420.00
124 rdf:rest N7bf299ddd9c4402e970a83af45be0413
125 N59c0c93bcf2d4f4ba0798b294a27444a schema:volumeNumber 17
126 rdf:type schema:PublicationVolume
127 N6370a04957344920998f7ff035bf1b71 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
128 schema:name Caspase 8
129 rdf:type schema:DefinedTerm
130 N666c4f20898e4f55a846809e40363eff schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
131 schema:name Apoptosis
132 rdf:type schema:DefinedTerm
133 N752e12e3162f4f57a3daa29ccc04d176 rdf:first sg:person.01136142016.09
134 rdf:rest Nbb81361eaac9400b817d56bab6055499
135 N7761f8bb2fd54287962318f895703e57 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
136 schema:name Cystatin B
137 rdf:type schema:DefinedTerm
138 N7b177bb7489c49efb0b14d1fc3c711aa rdf:first sg:person.01032164214.33
139 rdf:rest N578f701717b3428cae2d409a5c44fe32
140 N7bf299ddd9c4402e970a83af45be0413 rdf:first sg:person.01173405121.07
141 rdf:rest Ne5e69aaaa5304c1e922a5b311f167ff7
142 N89fe92b78413416faab7b0e6b6d4d1dd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
143 schema:name Repressor Proteins
144 rdf:type schema:DefinedTerm
145 N95b897cc2a864a36801b644d483f5f43 schema:name doi
146 schema:value 10.1038/cdd.2010.29
147 rdf:type schema:PropertyValue
148 Na2b1220108794ed1a7072f22813996a3 schema:name dimensions_id
149 schema:value pub.1035034614
150 rdf:type schema:PropertyValue
151 Na95a147c828f4b0ebf3c56e469ccc76b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
152 schema:name CASP8 and FADD-Like Apoptosis Regulating Protein
153 rdf:type schema:DefinedTerm
154 Nafe4cc1fbf6749b5a4386be89350173f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
155 schema:name Gene Knockdown Techniques
156 rdf:type schema:DefinedTerm
157 Nb49ceb21c45e4900838a85d1daa125b5 rdf:first sg:person.0617201523.26
158 rdf:rest N2bd267cd1da94cd5880bfe1b83732ed0
159 Nb608f8e88aaf48868462ac8386db475b schema:affiliation grid-institutes:grid.1013.3
160 schema:familyName Yang
161 schema:givenName E
162 rdf:type schema:Person
163 Nbb81361eaac9400b817d56bab6055499 rdf:first sg:person.01210202271.19
164 rdf:rest Nb49ceb21c45e4900838a85d1daa125b5
165 Nbf32d93d211e46e1aacde2aa99f0ce37 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
166 schema:name RNA, Small Interfering
167 rdf:type schema:DefinedTerm
168 Nc0bbecef9dd24feb9ab77c0391d445fd rdf:first sg:person.0755651204.44
169 rdf:rest N43d6eef20c2548f495e497249fadc3f4
170 Nc90084c4105746d598029b4f7ae3e881 schema:name Springer Nature - SN SciGraph project
171 rdf:type schema:Organization
172 Nd36c2511085f44f2a8e1f4b74cce5e35 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
173 schema:name RNA Interference
174 rdf:type schema:DefinedTerm
175 Nd391a4072161472c9563f53a91c0b28b schema:issueNumber 8
176 rdf:type schema:PublicationIssue
177 Ndd236ea2d327405aa2003274c2f1a1d2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
178 schema:name Humans
179 rdf:type schema:DefinedTerm
180 Ne5e69aaaa5304c1e922a5b311f167ff7 rdf:first sg:person.01073667716.42
181 rdf:rest N2a1aa56929d4403b92ea99ba9e35f5dd
182 Nebe8606b27e944a8951af343585f2b6a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
183 schema:name Melanoma
184 rdf:type schema:DefinedTerm
185 Nf530e5741d9442f0a82d7bbf3d7532e2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
186 schema:name Ubiquitin-Protein Ligases
187 rdf:type schema:DefinedTerm
188 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
189 schema:name Medical and Health Sciences
190 rdf:type schema:DefinedTerm
191 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
192 schema:name Oncology and Carcinogenesis
193 rdf:type schema:DefinedTerm
194 sg:journal.1112551 schema:issn 1350-9047
195 1476-5403
196 schema:name Cell Death & Differentiation
197 schema:publisher Springer Nature
198 rdf:type schema:Periodical
199 sg:person.01032164214.33 schema:affiliation grid-institutes:grid.413265.7
200 schema:familyName Tseng
201 schema:givenName H-Y
202 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01032164214.33
203 rdf:type schema:Person
204 sg:person.01073667716.42 schema:affiliation grid-institutes:grid.413265.7
205 schema:familyName Hersey
206 schema:givenName P
207 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01073667716.42
208 rdf:type schema:Person
209 sg:person.01136142016.09 schema:affiliation grid-institutes:grid.413265.7
210 schema:familyName Dong
211 schema:givenName L
212 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01136142016.09
213 rdf:type schema:Person
214 sg:person.01173405121.07 schema:affiliation grid-institutes:grid.1013.3
215 schema:familyName Christopherson
216 schema:givenName R
217 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01173405121.07
218 rdf:type schema:Person
219 sg:person.01204255216.26 schema:affiliation grid-institutes:grid.413265.7
220 schema:familyName Tay
221 schema:givenName K H
222 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01204255216.26
223 rdf:type schema:Person
224 sg:person.01210116316.18 schema:affiliation grid-institutes:grid.413265.7
225 schema:familyName Zhang
226 schema:givenName X D
227 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01210116316.18
228 rdf:type schema:Person
229 sg:person.01210202271.19 schema:affiliation grid-institutes:grid.413265.7
230 schema:familyName Thorne
231 schema:givenName R F
232 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01210202271.19
233 rdf:type schema:Person
234 sg:person.01212142420.00 schema:affiliation grid-institutes:grid.413265.7
235 schema:familyName Liu
236 schema:givenName H
237 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01212142420.00
238 rdf:type schema:Person
239 sg:person.0617201523.26 schema:affiliation grid-institutes:grid.413265.7
240 schema:familyName Jiang
241 schema:givenName C C
242 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0617201523.26
243 rdf:type schema:Person
244 sg:person.0755651204.44 schema:affiliation grid-institutes:grid.413265.7
245 schema:familyName Yang
246 schema:givenName F
247 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0755651204.44
248 rdf:type schema:Person
249 sg:pub.10.1007/s00432-005-0053-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031193330
250 https://doi.org/10.1007/s00432-005-0053-9
251 rdf:type schema:CreativeWork
252 sg:pub.10.1038/35101078 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021222128
253 https://doi.org/10.1038/35101078
254 rdf:type schema:CreativeWork
255 sg:pub.10.1038/40657 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027258655
256 https://doi.org/10.1038/40657
257 rdf:type schema:CreativeWork
258 sg:pub.10.1038/cdd.2009.35 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000450113
259 https://doi.org/10.1038/cdd.2009.35
260 rdf:type schema:CreativeWork
261 sg:pub.10.1038/onc.2008.299 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005671810
262 https://doi.org/10.1038/onc.2008.299
263 rdf:type schema:CreativeWork
264 sg:pub.10.1038/sj.cdd.4400859 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027216678
265 https://doi.org/10.1038/sj.cdd.4400859
266 rdf:type schema:CreativeWork
267 sg:pub.10.1038/sj.cdd.4401416 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038685270
268 https://doi.org/10.1038/sj.cdd.4401416
269 rdf:type schema:CreativeWork
270 sg:pub.10.1038/sj.onc.1204673 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000652031
271 https://doi.org/10.1038/sj.onc.1204673
272 rdf:type schema:CreativeWork
273 sg:pub.10.1038/sj.onc.1207512 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019973027
274 https://doi.org/10.1038/sj.onc.1207512
275 rdf:type schema:CreativeWork
276 sg:pub.10.1038/sj.onc.1210624 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022683071
277 https://doi.org/10.1038/sj.onc.1210624
278 rdf:type schema:CreativeWork
279 sg:pub.10.1038/sj.onc.1210924 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049640882
280 https://doi.org/10.1038/sj.onc.1210924
281 rdf:type schema:CreativeWork
282 grid-institutes:grid.1013.3 schema:alternateName School of Molecular and Microbial Biosciences, University of Sydney, 2006, Sydney, NSW, Australia
283 schema:name School of Molecular and Microbial Biosciences, University of Sydney, 2006, Sydney, NSW, Australia
284 rdf:type schema:Organization
285 grid-institutes:grid.413265.7 schema:alternateName Immunology and Oncology Unit, Calvary Mater Newcastle Hospital, 2300, Newcastle, NSW, Australia
286 schema:name Immunology and Oncology Unit, Calvary Mater Newcastle Hospital, 2300, Newcastle, NSW, Australia
287 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...